| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8745000 | Clinical Microbiology and Infection | 2017 | 19 Pages |
Abstract
The incidence of Gram-negative BSI significantly increased over time in this vulnerable patient population, providing evidence for reevaluating empiric therapy for neutropenic fever in HSCT patients.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. Weisser, C. Theilacker, S. Tschudin Sutter, R. Babikir, H. Bertz, T. Götting, M. Dettenkofer, W.V. Kern, A.F. Widmer,